JON ESPONGE: Open Payments
NPI 1609425008 · BROKEN ARROW, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,536 in 135 payments from 15 companies in 2025. Trend: 2023 $2,192 · 2024 $3,727 · 2025 $3,536
Food & beverage: $3,536
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $358 |
| Supernus Pharmaceuticals, Inc. | 13 | $351 |
| Vanda Pharmaceuticals Inc. | 13 | $341 |
| Neurocrine BioSciences, Inc. | 18 | $328 |
| Corium, LLC | 15 | $312 |
| Alkermes, Inc. | 11 | $305 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $280 |
| Axsome Therapeutics, Inc. | 5 | $279 |
| Janssen Pharmaceuticals, Inc | 2 | $252 |
| E.R. Squibb & Sons, L.L.C. | 7 | $223 |
Products named: VRAYLAR, Qelbree, FANAPT, INGREZZA, Azstarys, CAPLYTA, Auvelity, REXULTI.
Industry payments across OK — which companies pay providers there.
